Search research articles
Contact Us
Filters
Showing results (181-190 of 252) with videos related to
Page
of 26
Sort By:
Journal of the American College of Cardiology
|
January 1, 1995
Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 1: training in clinical cardiology
J S Alpert, W J Arnold, B R Chaitman, et al.
Pacing and Clinical Electrophysiology : PACE
|
March 1, 1986
Effects of AV sequential versus asynchronous AV pacing on pulmonary hemodynamics
L S Dreifus, H Mitamura, A Rhauda, et al.
Journal of Medicinal Chemistry
|
September 1, 1970
Synthesis and activity of some 3-aryl- and 3-aralkyl-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamides
B V Shetty, L A Campanella, T L Thomas, et al.
Archives of Internal Medicine
|
August 13, 2008
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
Hertzel C Gerstein, Karl Swedberg, Jonas Carlsson, et al.
American Journal of Hypertension
|
November 1, 1989
A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol
J A Schoenberger, J D Wallin, J I Gorwit, et al.
The American Journal of Cardiology
|
March 12, 1999
Effective dose range of candesartan cilexetil for systemic hypertension. Candesartan Cilexetil Study Investigators
T P Bell, V DeQuattro, K C Lasseter, et al.
Clinical Therapeutics
|
July 15, 1998
Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study Group
A H Gradman, N R Cutler, P J Davis, et al.
Circulation
|
February 1, 1988
Inducible sustained ventricular tachycardia 4 years after experimental canine myocardial infarction: electrophysiologic and anatomic comparisons with early healed infarcts
R F Hanich, C D de Langen, A H Kadish, et al.
The American Journal of Cardiology
|
May 1, 1978
Fascicular conduction distrubances after coronary bypass surgery
S M Zeldis, J Morganroth, L N Horowitz, et al.
The American Journal of Cardiology
|
October 30, 1998
Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators
M Reif, W B White, T C Fagan, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 252) with videos related to
Sort By:
Page
of 26
Journal of the American College of Cardiology
|
January 1, 1995
Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 1: training in clinical cardiology
J S Alpert, W J Arnold, B R Chaitman, et al.
Pacing and Clinical Electrophysiology : PACE
|
March 1, 1986
Effects of AV sequential versus asynchronous AV pacing on pulmonary hemodynamics
L S Dreifus, H Mitamura, A Rhauda, et al.
Journal of Medicinal Chemistry
|
September 1, 1970
Synthesis and activity of some 3-aryl- and 3-aralkyl-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamides
B V Shetty, L A Campanella, T L Thomas, et al.
Archives of Internal Medicine
|
August 13, 2008
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
Hertzel C Gerstein, Karl Swedberg, Jonas Carlsson, et al.
American Journal of Hypertension
|
November 1, 1989
A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol
J A Schoenberger, J D Wallin, J I Gorwit, et al.
The American Journal of Cardiology
|
March 12, 1999
Effective dose range of candesartan cilexetil for systemic hypertension. Candesartan Cilexetil Study Investigators
T P Bell, V DeQuattro, K C Lasseter, et al.
Clinical Therapeutics
|
July 15, 1998
Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study Group
A H Gradman, N R Cutler, P J Davis, et al.
Circulation
|
February 1, 1988
Inducible sustained ventricular tachycardia 4 years after experimental canine myocardial infarction: electrophysiologic and anatomic comparisons with early healed infarcts
R F Hanich, C D de Langen, A H Kadish, et al.
The American Journal of Cardiology
|
May 1, 1978
Fascicular conduction distrubances after coronary bypass surgery
S M Zeldis, J Morganroth, L N Horowitz, et al.
The American Journal of Cardiology
|
October 30, 1998
Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators
M Reif, W B White, T C Fagan, et al.
Page
of 26